共 11 条
Interference of the complex between NCS-1 and Ric8a with phenothiazines regulates synaptic function and is an approach for fragile X syndrome
被引:29
|作者:
Mansilla, Alicia
[1
]
Chaves-Sanjuan, Antonio
[2
]
Campillo, Nuria E.
[3
]
Semelidou, Ourania
[4
]
Martinez-Gonzalez, Loreto
[3
]
Infantes, Lourdes
[2
]
Maria Gonzalez-Rubio, Juana
[2
]
Gil, Carmen
[3
]
Conde, Santiago
[5
]
Skoulakis, Efthimios M. C.
[4
]
Ferrus, Alberto
[1
]
Martinez, Ana
[3
]
Jose Sanchez-Barrena, Maria
[2
]
机构:
[1] Spanish Natl Res Council, Inst Cajal, Dept Neurobiol Desarrollo, Madrid 28002, Spain
[2] Spanish Natl Res Council, Inst Quim Fis Rocasolano, Dept Cristalog & Biol Estruct, Madrid 28006, Spain
[3] Spanish Natl Res Council, Ctr Invest Biol, Madrid 28040, Spain
[4] Biomed Sci Res Ctr Alexander Fleming, Div Neurosci, Vari 16672, Greece
[5] Spanish Natl Res Council, Inst Quim Med, Madrid 28006, Spain
来源:
关键词:
fragile X syndrome;
synapse regulation;
NCS-1;
protein-protein interaction inhibitor;
X-ray crystallography;
MENTAL-RETARDATION PROTEIN;
NEURONAL CALCIUM SENSOR;
IMMUNOCYTOCHEMICAL LOCALIZATION;
STRUCTURAL INSIGHTS;
BINDING PROPERTIES;
CRYSTAL-STRUCTURE;
DROSOPHILA;
MEMORY;
INHIBITION;
FMRP;
D O I:
10.1073/pnas.1611089114
中图分类号:
O [数理科学和化学];
P [天文学、地球科学];
Q [生物科学];
N [自然科学总论];
学科分类号:
07 ;
0710 ;
09 ;
摘要:
The protein complex formed by the Ca2+ sensor neuronal calcium sensor 1 ( NCS-1) and the guanine exchange factor protein Ric8a coregulates synapse number and probability of neurotransmitter release, emerging as a potential therapeutic target for diseases affecting synapses, such as fragile X syndrome ( FXS), the most common heritable autism disorder. Using crystallographic data and the virtual screening of a chemical library, we identified a set of heterocyclic small molecules as potential inhibitors of the NCS-1/Ric8a interaction. The aminophenothiazine FD44 interferes with NCS-1/Ric8a binding, and it restores normal synapse number and associative learning in a Drosophila FXS model. The synaptic effects elicited by FD44 feeding are consistent with the genetic manipulation of NCS-1. The crystal structure of NCS-1 bound to FD44 and the structure-function studies performed with structurally close analogs explain the FD44 specificity and the mechanism of inhibition, in which the small molecule stabilizes a mobile C-terminal helix inside a hydrophobic crevice of NCS-1 to impede Ric8a interaction. Our study shows the drugability of the NCS-1/Ric8a interface and uncovers a suitable region in NCS-1 for development of additional drugs of potential use on FXS and related synaptic disorders.
引用
收藏
页码:E999 / E1008
页数:10
相关论文